Gerold Feuer, PhD

Dr. Feuer was one of the first investigators to establish ‘humanized’ mice as an in vivo model to characterize genetic determinants of human retroviral infections and pathogenesis (HTLV-1 and HIV-1), as a postdoc and Assistant Research Biologist at UCLA Medical Center. He established his academic laboratory in the Department of Microbiology and Immunology at SUNY Upstate Medical University, Syracuse, studying HTLV-1 and KSHV pathogenesis in humanized mice, as well as developing proprietary methods for isolating human hematopoietic (CD34+) stem cells, developing lentivirus vectors for transduction of human CD34+ cells. He established and served as the Director of SUNY UMU’s Center for Humanized SCID Mouse Models. HuMurine was founded in 2008 as a SUNY- academic spinoff company and was the first company to commercialize the humanized immune system mouse. HuMurine laboratory operations relocated to adjacent to the U.C. Davis Medical Center and Institute for Regenerative Cures in Sacramento, CA, in 2011. After running HuMurine, Dr. Feuer joined Crown Bioscience full time in 2021. He has an extensive background in the fields of human virology, immuno-oncology, lentiviral vector gene therapies and human hematopoietic stem cells.